Cronos Group Inc. (NASDAQ:CRON - Get Free Report)'s share price hit a new 52-week low during trading on Monday . The stock traded as low as $1.83 and last traded at $1.84, with a volume of 92246 shares changing hands. The stock had previously closed at $1.90.
Cronos Group Stock Performance
The company has a market capitalization of $772.25 million, a price-to-earnings ratio of -15.54, a PEG ratio of 1.71 and a beta of 0.97. The business's 50 day moving average is $1.98 and its 200 day moving average is $2.13.
Institutional Trading of Cronos Group
A number of institutional investors and hedge funds have recently added to or reduced their stakes in CRON. Thompson Davis & CO. Inc. acquired a new position in shares of Cronos Group in the fourth quarter valued at about $29,000. SBI Securities Co. Ltd. purchased a new position in Cronos Group during the 4th quarter worth approximately $30,000. Jones Financial Companies Lllp raised its position in Cronos Group by 64.5% during the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after buying an additional 6,520 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Cronos Group in the 3rd quarter valued at $37,000. Finally, International Assets Investment Management LLC boosted its holdings in shares of Cronos Group by 119.0% in the 3rd quarter. International Assets Investment Management LLC now owns 41,643 shares of the company's stock valued at $91,000 after acquiring an additional 22,628 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company's stock.
Cronos Group Company Profile
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Further Reading
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
